ArticleAntibiotics (Basel, Switzerland)2020

Critical Parameters for the Development of Novel Therapies for Severe and Resistant Infections-A Case Study on CAL02, a Non-Traditional Broad-Spectrum Anti-Virulence Drug.

Samareh Azeredo da Silveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.